Regeneron Pharmaceuticals (NASDAQ:REGN) PT Raised to $1,030.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by TD Cowen from $1,020.00 to $1,030.00 in a report published on Wednesday morning, Benzinga reports. TD Cowen currently has a buy rating on the biopharmaceutical company’s stock. Several other equities analysts have also recently weighed in on REGN. StockNews.com cut shares of Regeneron […]